8-KThe WireStrategic
Material Agreement · Equity Issuance
Filed Feb 20, 2025 · 1y ago · Accession 0001193125-25-030143
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- UroGen Pharma Ltd.
- Ticker
- URGN
- CIK
- 1668243
- Form type
- 8-K
- Filing date
- Feb 20, 2025
- Report date
- Feb 14, 2025
- Document
- d897858d8k.htm
- Size
- 145 KB